# Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical Cancer

> **NCT05188716** · — · COMPLETED · sponsor: **Chuangzhen Chen** · enrollment: 30 (actual)

## Conditions studied

- Cervical Cancer
- Benign Tumor of Uterus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05188716
- **Lead sponsor:** Chuangzhen Chen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-10
- **Primary completion:** 2021-10-13
- **Final completion:** 2022-01-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05188716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05188716, "Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05188716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*